Literature DB >> 30074878

Detection and Evaluation of Antibody Response to a Baylisascaris-Specific Antigen in Rodent Hosts with the Use of Western Blotting and Elisa.

Sarah G H Sapp1,2, Sukwan Handali3, Sara B Weinstein4, Michael J Yabsley1,5.   

Abstract

Diagnosis of parasitic diseases that involve tissue-stage larvae is challenging, and serology remains the most effective antemortem test for detecting these infections. Baylisascaris procyonis, the raccoon roundworm, is a zoonotic ascarid. Raccoons are the usual definitive host, and humans may be infected as accidental hosts. More than 150 species of birds and mammals may act as paratenic hosts, and rodents play an important role in the transmission and maintenance of this parasite in nature. Migratory larvae in paratenic host tissues can produce ocular disease and severe to fatal neurologic disease, but not all infected hosts develop signs. A sensitive and specific Western blot (WB) assay based on a recombinant Baylisascaris-specific antigen (rBpRAG-1) has been developed for use in humans. We evaluated the use of this antigen to detect Baylisascaris spp. infections in rodent paratenic hosts. With the use of 4 species of Peromyscus mice ( Peromyscus californicus, Peromyscus leucopus, Peromyscus maniculatus, Peromyscus polionotus) from a previous infection trial, we developed species-adapted WB and ELISA assays and evaluated performance compared to detection of larvae in tissue samples. These assays revealed species-level differences in seroconversion and terminal antibody concentrations, with P. leucopus developing significantly greater antibody concentrations than P. californicus and P. polionotus at all dose levels, and P. maniculatus at the low dose. Some P. californicus and P. polionotus failed to seroconvert despite the recovery of larvae from their tissues. WB and ELISA results were correlated; however, the WB demonstrated higher sensitivity than the ELISA overall (72.2% versus 63.9%, respectively). With the use of experimental samples, specificity was 100% for WB and 94.1% for ELISA. A WB was also used to test Mus and Rattus samples, and although numbers were too limited to evaluate sensitivity and specificity, all animals known to be infected by tissue digestion were WB positive, and all uninfected animals were negative. Finally, the Peromyscus-adapted WB and ELISA were used to test a set of serum samples from wild-trapped P. maniculatus and Rattus rattus. Both assays were generally sensitive, but specificity was equivocal. This emphasizes the challenge of using serology for investigation of wildlife diseases, in which hosts have unknown exposure histories. Nevertheless, serologic methods have utility in the study of Baylisascaris spp. in paratenic hosts, either wild or captive, and have advantageous attributes (non-lethal, high-throughput), but results should be interpreted carefully.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30074878      PMCID: PMC7646972          DOI: 10.1645/18-48

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  26 in total

1.  Molecular cloning of an immunogenic protein of Baylisascaris procyonis and expression in Escherichia coli for use in developing improved serodiagnostic assays.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Kathy Hancock; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Introduced Rats and an Endemic Roundworm: Does Rattus rattus Contribute to Baylisascaris procyonis Transmission in California?

Authors:  Sara B Weinstein
Journal:  J Parasitol       Date:  2017-07-21       Impact factor: 1.276

3.  Comparative analysis of larval excretory-secretory antigens of Baylisascaris procyonis, Toxocara canis and Ascaris suum by Western blotting and enzyme immunoassay.

Authors:  W M Boyce; B A Branstetter; K R Kazacos
Journal:  Int J Parasitol       Date:  1988-02       Impact factor: 3.981

4.  Immunodiagnosis of Besnoitia besnoiti infection by ELISA and Western blot.

Authors:  H C E Cortes; S Nunes; Y Reis; D Staubli; R Vidal; H Sager; A Leitão; B Gottstein
Journal:  Vet Parasitol       Date:  2006-07-05       Impact factor: 2.738

5.  Toxocara canis: monoclonal antibodies to larval excretory-secretory antigens that bind with genus and species specificity to the cuticular surface of infective larvae.

Authors:  D D Bowman; M Mika-Grieve; R B Grieve
Journal:  Exp Parasitol       Date:  1987-12       Impact factor: 2.011

6.  Toxocara canis: effect of inoculum size on pulmonary pathology and cytokine expression in BALB/c mice.

Authors:  Elena Pinelli; Sietze Brandes; Jan Dormans; Manoj Fonville; Clare M Hamilton; Joke van der Giessen
Journal:  Exp Parasitol       Date:  2006-09-05       Impact factor: 2.011

7.  Interlaboratory optimization and evaluation of a serological assay for diagnosis of human baylisascariasis.

Authors:  Lisa N Rascoe; Cynthia Santamaria; Sukwan Handali; Sriveny Dangoudoubiyam; Kevin R Kazacos; Patricia P Wilkins; Momar Ndao
Journal:  Clin Vaccine Immunol       Date:  2013-09-18

8.  Laboratory diagnosis of human toxocariasis.

Authors:  J Fillaux; J-F Magnaval
Journal:  Vet Parasitol       Date:  2012-12-20       Impact factor: 2.738

9.  Effect of various doses of infective Toxocara canis and Toxocara cati eggs on the humoral response and distribution of larvae in mice.

Authors:  K Havasiová-Reiterová; O Tomasovicová; P Dubinský
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

10.  Seroprevalence of Baylisascaris procyonis Infection among Humans, Santa Barbara County, California, USA, 2014-2016.

Authors:  Sara B Weinstein; Camille M Lake; Holly M Chastain; David Fisk; Sukwan Handali; Philip L Kahn; Susan P Montgomery; Patricia P Wilkins; Armand M Kuris; Kevin D Lafferty
Journal:  Emerg Infect Dis       Date:  2017-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.